Skip to content
OpenCapital
Get started
OrthoPediatrics logo

OrthoPediatrics (KIDS) Q1 2026 Earnings

KIDS·Reported April 30, 2026·After market close

OrthoPediatrics reported Q1 2026 revenue of $59.4M (+13.3% YoY), beat analyst consensus of $58.3M by $1.1M. Diluted EPS came in at $-0.42 (-7.7% YoY), missed the $-0.38 consensus by $0.04.

Revenue
$59.4Mbeat by $1.1M
Consensus: $58.3M
Diluted EPS
$-0.42missed by $0.04
Consensus: $-0.38
SEC

SEC Filings

Earnings release8-K · 0001425450-26-000032
Quarterly report10-Q · 0001425450-26-000036

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about OrthoPediatrics's Q1 2026 earnings report.

OrthoPediatrics (KIDS) reported Q1 2026 earnings on April 30, 2026 after market close.

OrthoPediatrics reported revenue of $59.4M and diluted EPS of $-0.42 for Q1 2026.

Revenue beat the consensus estimate of $58.3M by $1.1M. EPS missed the consensus estimate of $-0.38 by $0.04.

Compared to the same quarter a year prior, revenue grew 13.3% from $52.4M a year earlier and diluted EPS declined 7.7% from $-0.39.

You can read the 8-K earnings release (0001425450-26-000032) and the 10-Q periodic report (0001425450-26-000036) directly on SEC EDGAR. The filing index links above go to sec.gov.